Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity - Summary - MDSpire
Advertisement
Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
To evaluate early postoperative surgery-related morbidity and the level of evidence comparing duodenum-preserving pancreatic head resection (DPPHR) and pancreatoduodenectomy (PD) specifically for benign tumors.
Key Findings:
DPPHR shows lower rates of new-onset diabetes mellitus (DM) and pancreatic exocrine insufficiency (PEI) compared to PD, with statistical significance.
In-hospital mortality for PD ranges from 2-4%, with 90-day mortality above 4%, indicating substantial risks.
Postoperative new-onset DM occurs in 14-20% and new-onset PEI in 34-45% of patients undergoing PD, emphasizing the metabolic complications.
Interpretation:
DPPHR may provide a safer alternative to PD for benign pancreatic tumors, with reduced metabolic complications and lower early postoperative morbidity, suggesting a shift in surgical practice.
Limitations:
Lack of data on early postoperative morbidity specifically for DPPHR, which limits the generalizability of findings.
Variability in study quality and methodologies among included studies may affect the reliability of conclusions drawn.
Conclusion:
DPPHR is associated with lower surgical morbidity and better preservation of pancreatic function compared to traditional PD for benign tumors, highlighting its potential as a preferred surgical option.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
